STC2 and Other metabolic disease: Given that STC2 treatment improved metabolic disorders in ob/ob mice, the mRNA levels of adipogenic genes, hepatic gluconeogenic genes, hepatic triglyceride synthesis related genes were analyzed in ob/ob mice.